Literature DB >> 19546020

The official positions of the International Society for Clinical Densitometry: perceptions and commentary.

E Michael Lewiecki1, Sanford Baim, Craig B Langman, John P Bilezikian.   

Abstract

The International Society for Clinical Densitometry (ISCD) periodically issues Official Positions (OPs) on the assessment of skeletal health in adults and children. OPs are recommendations regarding topics that include nomenclature, indications, acquisition, analysis, quality control, interpretation, reporting, and clinical utility of measuring bone density using different technologies. The purpose of these directives is to assist health care professionals in the practice of clinical densitometry. The OPs are established through a rigorous process of scientific literature review by ISCD task forces, each assigned to address a group of clinically relevant questions. The findings and recommendations of each task force are assessed and revised, as needed, by an international panel of experts. Recommendations that are felt to be appropriate for inclusion as ISCD OPs are sent to the ISCD Board of Directors for final approval. Despite having a major impact in the clinical application of bone densitometry, the ISCD OPs have not been universally adopted, in part because of misunderstanding of the process used to establish them and the way that they are intended for use in clinical practice. This is a review of the benefits and limitations of the ISCD OPs with emphasis on areas of controversy.

Entities:  

Mesh:

Year:  2009        PMID: 19546020     DOI: 10.1016/j.jocd.2009.03.098

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  9 in total

1.  Pediatrics: Measuring pediatric BMD-the bar raised but the glass half full.

Authors:  Craig B Langman
Journal:  Nat Rev Endocrinol       Date:  2011-11-22       Impact factor: 43.330

2.  Possible mechanisms for the skeletal effects of antipsychotics in children and adolescents.

Authors:  Chadi A Calarge; Stephanie D Ivins; Katherine J Motyl; Amal A Shibli-Rahhal; Michael M Bliziotes; Janet A Schlechte
Journal:  Ther Adv Psychopharmacol       Date:  2013-10

3.  Phalangeal quantitative ultrasound in 1,719 children and adolescents with bone disorders.

Authors:  A Mussa; F Porta; G Baldassarre; G Tuli; F de Terlizzi; P Matarazzo; S Einaudi; R Lala; A Corrias
Journal:  Osteoporos Int       Date:  2011-09-23       Impact factor: 4.507

Review 4.  Osteoporosis imaging: state of the art and advanced imaging.

Authors:  Thomas M Link
Journal:  Radiology       Date:  2012-04       Impact factor: 11.105

Review 5.  Update on Imaging-Based Measurement of Bone Mineral Density and Quality.

Authors:  Thomas M Link; Galateia Kazakia
Journal:  Curr Rheumatol Rep       Date:  2020-04-09       Impact factor: 4.592

Review 6.  Idiopathic osteoporosis in men.

Authors:  Luigi Gennari; John P Bilezikian
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

7.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop.

Authors:  John P Bilezikian; Maria Luisa Brandi; Richard Eastell; Shonni J Silverberg; Robert Udelsman; Claudio Marcocci; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958

8.  Atypical parathyroid adenoma: clinical and anatomical pathologic features.

Authors:  Alessandro Galani; Riccardo Morandi; Mira Dimko; Sarah Molfino; Carla Baronchelli; Silvia Lai; Federico Gheza; Carlo Cappelli; Claudio Casella
Journal:  World J Surg Oncol       Date:  2021-01-20       Impact factor: 2.754

9.  Intake of dehydrated nopal (Opuntia ficus indica) improves bone mineral density and calciuria in adult Mexican women.

Authors:  María de Los Angeles Aguilera-Barreiro; José Alberto Rivera-Márquez; Héctor Miguel Trujillo-Arriaga; Juan Alfredo Tamayo Y Orozco; Eduardo Barreira-Mercado; Mario E Rodríguez-García
Journal:  Food Nutr Res       Date:  2013-05-21       Impact factor: 3.894

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.